Atlas Trials

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

Clinical trial NCT07134153 · RECRUITING

Trial details

NCT number
NCT07134153
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-04-18
Primary completion
2026-08-30
Enrollment
139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.